| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |